Related Experiment Video
Updated: May 27, 2026

08:00
Scalable 96-well Plate Based iPSC Culture and Production Using a Robotic Liquid Handling System
Published on: May 14, 2015
Surface-engineered substrates for improved human pluripotent stem cell culture under fully defined conditions.
Krishanu Saha1, Ying Mei, Colin M Reisterer
1The Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA.
Summary
Researchers developed a novel surface for culturing human pluripotent stem cells (hPSCs). This feeder-free system significantly enhances hPSC growth and facilitates reprogramming, offering a scalable platform for cell therapies.
Area of Science:
- Stem Cell Biology
- Biomaterials Science
- Surface Chemistry
Background:
- Current human pluripotent stem cell (hPSC) culture relies on feeder layers, which complicate downstream applications.
- Developing feeder-free systems is crucial for clinical translation and scalable hPSC expansion.
Purpose of the Study:
- To engineer a chemically defined, xeno-free substrate for efficient hPSC culture.
- To optimize surface properties for enhanced cell aggregation, growth, and genetic manipulation of hPSCs.
Main Methods:
- Modification of standard cell culture plastics using UV/ozone radiation.
- Chemical and geometrical surface characterization and optimization.
- Numerical modeling of cell migration to predict aggregation behavior.
- Assessment of hPSC proliferation, reprogramming, and gene targeting on engineered surfaces.
Main Results:
- UV/ozone treated surfaces promote controlled early cell aggregation from dissociated hPSCs.
- Engineered substrates significantly increase undifferentiated hPSC growth compared to feeder-based cultures.
- The chemically defined, xeno-free substrates yield over three times more cells per surface area.
- Reprogramming and gene-targeting protocols are successfully performed on these novel surfaces.
Conclusions:
- Spatially defined culture surfaces offer a superior alternative to feeder layers for hPSC expansion.
- These engineered substrates provide a scalable and standardized platform for clinical applications, including cell therapy and disease modeling.
- The developed system supports factor-free reprogramming, enabling the production of clinically relevant cells from patient samples.

